tiprankstipranks
Trending News
More News >
Paradigm Biopharmaceuticals Ltd. (AU:PAR)
ASX:PAR

Compare Paradigm Biopharmaceuticals (PAR) vs. Competitors

Compare
39 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Paradigm Biopharmaceuticals
AU$0.33
AU$132.22M
-6.14
-45.05%
Imugene
AU$0.33
AU$90.02M
-0.89
-77.74%
Alterity Therapeutics
AU$0.01
AU$76.13M
-5.26
0.00%
1 Buy
0 Hold
0 Sell
Moderate Buy
Pharmaust Limited
AU$0.10
AU$61.98M
-2.69
-26.23%
Recce Pharmaceuticals Ltd.
AU$0.41
AU$161.94M
-6.22
23.08%
Arovella Therapeutics Limited
AU$0.08
AU$103.30M
-12.65
-54.74%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AU:PAR
Paradigm Biopharmaceuticals
0.31
-0.28
-47.86%
AU:IMU
Imugene
0.28
-0.94
-77.12%
AU:ATH
Alterity Therapeutics
0.01
>-0.01
-16.67%
AU:NUZ
Pharmaust Limited
0.09
-0.03
-26.23%
AU:RCE
Recce Pharmaceuticals Ltd.
0.56
0.11
23.08%
AU:ALA
Arovella Therapeutics Limited
0.09
-0.10
-54.74%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts